Germany has ordered 40,000 doses of the smallpox vaccine Imvanex, from Bavarian Nordic, in preparation for a possible immunization campaign if the outbreak of the disease becomes more serious in the country.
In a press conference, German Health Minister Karl Lauterbach said this Tuesday (24) that, for now, he is counting on a period of isolation of at least 21 days of infected people to contain the outbreak.
So far, five cases have been reported in Germany, all in men, said Lothar Wieler, head of Germany’s Robert Koch Institute for Infectious Diseases, also during the press conference.
US considers releasing vaccine for high-risk people
The United States responds to a request to release the monkeypox vaccine from the country’s Strategic National Stockpile in the face of the global surge in cases under investigation.
There is one confirmed case of smallpox and four suspected cases in the United States, according to the US Centers for Disease Control and Prevention (CDC).
“I can report that there has been an order for the Jynneos vaccine to be released from the National Stockpile for some of the high-risk contacts of some of the early patients, so that is actively happening now,” said Jennifer McQuiston, deputy director of the Division of Pathogens and Pathology. of High Consequence from the CDC’s National Center for Emerging and Zoonotic Infectious Diseases on Monday.
Jennifer said the United States has a “good supply” of vaccine because it is preparing for the possibility of needing to use doses for smallpox.
In the United States, the two-dose Jynneos vaccine is licensed to prevent smallpox and specifically to prevent monkeypox.
(Edited by Madeline Chambers; with input from Jacqueline Howard and Virginia Langmaid of CNN)
Source: CNN Brasil
